Hideki Nagao is Director at MEDICINOVA INC (MNOV). They have made 5 open-market trades across 1 company since 2020, most recently 2022-11-28.
CIK 0001315306
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MNOV | 6,754 | $10K |
Shares reported on the most recent Form 4, priced at the 2022-11-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MNOV | SELL | 2022-11-28 | 2022-11-30 | $2.25 | $15K | -5.3% | -24.8% | -19.3% |
| MNOV | SELL | 2022-11-21 | 2022-11-23 | $2.18 | $12K | +8.1% | -9.5% | +4.1% |
| MNOV | SELL | 2022-11-17 | 2022-11-21 | $2.18 | $674 | +21.0% | +5.1% | +7.5% |
| MNOV | SELL | 2021-03-11 | 2021-03-15 | $7.40 | $17K | -20.3% | -27.1% | -33.4% |
| MNOV | SELL | 2020-09-15 | 2020-09-16 | $5.78 | $6K | -15.1% | -8.0% | +6.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.